1-3 of 3
Authors: Navaldeep Singh
Sort by
Journal Article
Pharmacodynamics of aztreonam/ceftazidime/avibactam and polymyxin B versus New Delhi MBL-producing Acinetobacter baumannii
Jacob T Dumbleton and others
JAC-Antimicrobial Resistance, Volume 7, Issue 3, June 2025, dlaf068, https://doi.org/10.1093/jacamr/dlaf068
Published: 02 May 2025
Journal Article
P-1064. Safety, Tolerability, and Pharmacokinetics of Rifaquizone for Injection in Healthy Participants in China: A Single-center, Double-blind, Randomized, Placebo-controlled, Phase 1 Bridge Study
Xiaojie Wu and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.1253, https://doi.org/10.1093/ofid/ofae631.1253
Published: 29 January 2025
Journal Article
2170. It takes two to tango: ß-lactam/ß-lactamase inhibitor combinations targeting metallo-ß-lactamase (MBL)- producing Klebsiella pneumoniae.
Jan Naseer Kaur and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.1792, https://doi.org/10.1093/ofid/ofad500.1792
Published: 27 November 2023
Advertisement
Advertisement